By Robert Bazell Chief science and health correspondent
NBC News
updated 9/12/2011 4:01:28 PM ET 2011-09-12T20:01:28

A new study released Monday shows that insulin applied daily through a special nasal spray might be a treatment that slows or stops the progression of Alzheimer’s disease. That’s hopeful news for millions facing the memory-robbing disease, because nothing has been successful at halting its awful progress.

  1. Don't miss these Health stories
    1. Splash News
      More women opting for preventive mastectomy - but should they be?

      Rates of women who are opting for preventive mastectomies, such as Angeline Jolie, have increased by an estimated 50 percent in recent years, experts say. But many doctors are puzzled because the operation doesn't carry a 100 percent guarantee, it's major surgery -- and women have other options, from a once-a-day pill to careful monitoring.

    2. Larry Page's damaged vocal cords: Treatment comes with trade-offs
    3. Report questioning salt guidelines riles heart experts
    4. CDC: 2012 was deadliest year for West Nile in US
    5. What stresses moms most? Themselves, survey says

In the small study, called a Phase II, researchers from the Veterans Affairs Puget Sound Health Care System in Seattle, enrolled 104 people with Alzheimer’s or mild cognitive impairment. The participants were given 20 IU (international units) of insulin, 40 IU of insulint or a saline placebo. Memory, cognition and functional ability were measured before and after treatment. Some of the participants also received lumbar punctures to test cerebrospinal fluid and brain scans before and after treatment.

Adults treated with 20 IU of the insulin nasal spray experienced improved memory and both doses of insulin protected general cognition and ability to function. But the study lasted only four months.

It is critical to note that that if this treatment works in larger studies, it will not be available to patients for a few years, at least.

To make these findings more than just hopeful, researchers must carry out a much larger, longer study, now scheduled to begin next summer. Results from the larger study will not be available for at least 18 months after that.

"Lots of things have looked very promising in the early Phase II studies and we put them into a larger trial and we find nothing," Dr. Laurie Ryan, the clinical trials co-coordinator at the National Institute on Aging, which sponsored the research, warns.

The article is available free at Archives of Neurology

Using insulin, the protein that regulates the body’s metabolism of glucose, for Alzheimer’s might seem unusual. But in recent years, many studies in humans and animals have found that the insulin resistance which is the hallmark of type 2 diabetes plays a critical role in the develop of Alzheimer’s. The brains of people with Alzheimer’s either lack normal levels of insulin or are unable to metabolize the amounts that are present.

However, simply giving a person insulin with the usual method used to treat diabetes would not solve the problem. In fact, it could be very dangerous.

Psychiatrist Dr. Suzanne Craft and her team at the University of Washington and the Puget Sound VA developed a special device that inserts the insulin into the sinus cavities closest to the brain. From there, the protein travels along nerve cells reaching the brain within 15 to 20 minutes.

Using memory tests and brain scans that show the chemical changes typical of Alzheimer’s, the University of Washington team found that two-thirds to three-fourths of the patients taking insulin improved, compared to those taking a placebo, a dummy medication.

“Most medications for Alzheimer’s disease benefit relatively fewer patients,” Craft said.  “So, from that standpoint we were surprised by how many of the participants benefited.”

Story: Early Alzheimer's disclosures to become more common

Recently most of the news about Alzheimer’s has described large, failed trials. But in addition to insulin, other drugs are showing some progress in early trials.

Neurologist Dr. Dennis Selkoe, a pioneering Alzheimer’s researcher at Brigham and Women’s Hospital in Boston wrote recently  “Our field is in a sensitive situation; its promise is palpable, but its potential for disappointment is great.”

© 2013  Reprints

Video: New treatment for Alzheimer’s ‘promising’

  1. Closed captioning of: New treatment for Alzheimer’s ‘promising’

    >> a big health news story. as we mentioned earlier tonight we have the first glimmer of hope in the fight against alzheimer 's in a long time. while there, of course, is no cure and while it's hard to find an american family without some connection to alzheimer 's, a new study funded by the national institutes of health has found that an insulin nasal spray , of all things, has shown memory improvement in some patients. research like this is a prong of the administration's effort to develop the first so-called national alzheimer 's plan and we get our report tonight from our chief science correspondent robert bazell .

    >> i'm going to demonstrate for you --

    >> reporter: it could be a dramatic new treatment for alzheimer 's disease.

    >> it's very promising. we're very excited about it. we'd like to see it move forward into a larger trial.

    >> reporter: dr. suzanne craft and her team gave volunteers a dose of a special insulin nasal spray or a placebo. the 104 participants had alzheimer 's or, like john martin , prealzheimer's memory problems. after four months, three-quarters of people getting the insulin spray did better on memory tests.

    >> children saw lions --

    >> reporter: and on scans showing brain changes that signal memory loss .

    >> we were surprised by how many of the participants benefitted.

    >> reporter: why insulin? recent studies show a strong connection between insulin resistance and many symptoms of alzheimer 's disease. insulin helps the body use sugar. if that doesn't happen properly in the brain it can lead to memory loss . in this experiment the scientists used the spray to get insulin into the scieninuses.

    >> it reaches the brain quickly.

    >> reporter: people should not try to treat alzheimer 's with insulin used to treat buy details. it could be dangerous or life thenning. a longer study should reveal whether the hopeful beginning marks genuine progress against a heart-breaking disease that so far has been unstoppable.

    >> here's the device.

    >> reporter: robert bazell , nbc news, new york.


Discussion comments


Most active discussions

  1. votes comments
  2. votes comments
  3. votes comments
  4. votes comments